ESP Block VS TAP in Laparoscopic Hysterectomy

• Status: Completed
• Trial end date: 2021-03-04
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to compare the difference between two different pain control methods in patients who will be having a hysterectomy surgery. By collecting this data, we aim to show improved postoperative pain scores, decreased opioid needs, and decreased opioid side effects (nausea, sedation, ileus, urinary retention, respiratory depression).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Indiana University
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Patients undergoing laparoscopic hysterectomy surgery at Indiana University Hospital

• ASA class 1, 2, 3 or 4

• Age 18 or older, female

• Desires Regional anesthesia for postoperative pain control

Exclusion Criteria:

• History of substance abuse in the past 6 months.

• Patients on more than 30 mg morphine equivalents of opioids.

• Any physical, mental or medical conditions which in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery.

• Known allergy or other contraindications to the study medications (Acetaminophen, Gabapentin, Bupivacaine).

• Postoperative intubation.

• Any BMI greater than 40.0.